NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
出版年份 2020 全文链接
标题
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
作者
关键词
-
出版物
GUT
Volume -, Issue -, Pages gutjnl-2020-320622
出版商
BMJ
发表日期
2020-04-23
DOI
10.1136/gutjnl-2020-320622
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease
- (2020) Jacqueline B. Henson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals
- (2020) Xiuli Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
- (2020) Silvia Sookoian et al. GUT
- Is NAFLD Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart
- (2020) Jacqueline B. Henson et al. HEPATOLOGY
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease
- (2020) James M. Paik et al. HEPATOLOGY
- NAFLD as a driver of chronic kidney disease
- (2020) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury
- (2020) Chuanjie Wu et al. NEUROLOGY
- Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map
- (2020) Jianhong Zhu et al. Lancet Diabetes & Endocrinology
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
- (2019) Cyrielle Caussy et al. Nature Communications
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients
- (2019) Paola Dongiovanni et al. JOURNAL OF LIPID RESEARCH
- Metformin and gut microbiota: their interactions and their impact on diabetes
- (2019) Natalia G. Vallianou et al. Hormones-International Journal of Endocrinology and Metabolism
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial
- (2019) Kathleen E. Corey et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
- (2019) Gianluca Svegliati-Baroni et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis
- (2019) Anissa A. Widjaja et al. GASTROENTEROLOGY
- Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways
- (2019) Guannan Meng et al. EBioMedicine
- Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease
- (2019) Jeffrey B. Schwimmer et al. GASTROENTEROLOGY
- The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
- (2019) Dan-Ying Zhang et al. Drug Design Development and Therapy
- Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids
- (2019) Jian-Mei Li et al. Microbiome
- Class effects of SGLT2 inhibitors on cardiorenal outcomes
- (2019) Aaron Y. Kluger et al. Cardiovascular Diabetology
- Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
- (2019) Sifan Chen et al. Cell Metabolism
- Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography
- (2019) A. Mantovani et al. DIABETES & METABOLISM
- Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study
- (2019) Chikara Iino et al. Hepatology International
- Hepatocyte-Derived Extracellular Vesicles Promote Endothelial Inflammation and Atherogenesis via microRNA-1
- (2019) Fangjie Jiang et al. JOURNAL OF HEPATOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
- (2019) Jiyeon Kim et al. Frontiers in Microbiology
- Gut Microbiome and Response to Cardiovascular Drugs
- (2019) Sony Tuteja et al. Circulation-Genomic and Precision Medicine
- Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease
- (2019) Alina M. Allen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease
- (2019) Yiwen Zhang et al. BMC GENOMICS
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
- (2019) Martijn C. G. J. Brouwers et al. DIABETOLOGIA
- CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES – 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS
- (2019) Jeffrey I. Mechanick et al. Endocrine Practice
- Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
- (2019) Carmen Roncal et al. Scientific Reports
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany
- (2019) Christian Labenz et al. DIGESTIVE DISEASES AND SCIENCES
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Can we still learn from the Seven Countries Study?
- (2018) Alessandro Menotti et al. CURRENT OPINION IN LIPIDOLOGY
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
- (2018) Giovanni Musso et al. GASTROENTEROLOGY
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis
- (2018) Tracey G. Simon et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study
- (2018) Seung Bum Lee et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
- (2018) Lesley Hoyles et al. NATURE MEDICINE
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
- (2018) Hannah E. Da Silva et al. Scientific Reports
- Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
- (2018) Loek P. Smits et al. Journal of the American Heart Association
- The complex crosstalk between inflammatory cytokines and ventricular arrhythmias
- (2018) N. Kouvas et al. CYTOKINE
- Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure
- (2018) Shih-Lin Chang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiovascular risk factors in non-alcoholic fatty liver disease
- (2018) Hannes Hagström et al. LIVER INTERNATIONAL
- Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
- (2018) Adam B. Roberts et al. NATURE MEDICINE
- Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
- (2018) Alen Lovric et al. Scientific Reports
- A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
- (2018) Amedeo Lonardo et al. ACTA DIABETOLOGICA
- Liver Fat is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study
- (2018) Zachary P. Fricker et al. Clinical Gastroenterology and Hepatology
- Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women
- (2018) Zeneng Wang et al. EUROPEAN HEART JOURNAL
- FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
- (2018) Elliot S. Friedman et al. GASTROENTEROLOGY
- Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study
- (2018) Yoosoo Chang et al. GUT
- l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
- (2018) Robert A. Koeth et al. JOURNAL OF CLINICAL INVESTIGATION
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism
- (2018) Martin F. Reiner et al. THROMBOSIS RESEARCH
- Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
- (2017) Gabriele Giacomo Schiattarella et al. EUROPEAN HEART JOURNAL
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies
- (2017) Jiaqian Qi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer’s Disease
- (2017) Patricia Martín-Maestro et al. Oxidative Medicine and Cellular Longevity
- Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
- (2017) Mariana X. Byndloss et al. SCIENCE
- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
- (2017) Walter N. Kernan et al. JAMA Neurology
- Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells
- (2017) Malgorzata Nepelska et al. Scientific Reports
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
- (2016) Weifei Zhu et al. CELL
- Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
- (2016) Alessandro Mantovani et al. DIGESTIVE DISEASES AND SCIENCES
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
- (2016) Dong Hyun Sinn et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
- (2016) Dong Hyun Sinn et al. GUT
- Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach
- (2016) Federica Del Chierico et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Non-alcoholic fatty liver disease and risk of cardiovascular disease
- (2016) Amedeo Lonardo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice
- (2016) Gustavo Monnerat et al. Nature Communications
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
- (2016) Yu-ming Chen et al. Scientific Reports
- Importance of sex and gender in atherosclerosis and cardiovascular disease
- (2015) J. David Spence et al. ATHEROSCLEROSIS
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα
- (2015) Roozbeh Aschar-Sobbi et al. Nature Communications
- Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
- (2014) Ki-Chul Sung et al. JOURNAL OF HEPATOLOGY
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis
- (2013) Na Wu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
- (2013) W.H. Wilson Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
- (2012) David van der Poorten et al. HEPATOLOGY
- The Framingham risk score and heart disease in nonalcoholic fatty liver disease
- (2012) Sombat Treeprasertsuk et al. LIVER INTERNATIONAL
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Unknown
- (2011) Alexander Moschen et al. MOLECULAR MEDICINE
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor expression
- (2010) A. R. Moschen et al. GUT
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
- (2009) Sarah Rosner Preis et al. CIRCULATION
- Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis
- (2009) Ebru Erbay et al. NATURE MEDICINE
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
- (2008) Winston Dunn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started